Intensive rehabilitation program for patients with functional motor disorders: 3-years’ experience.
Objective: To describe the clinical characteristics and the outcomes of a cohort of patients with functional movement disorders (FMD) who attended the FMD clinic of…Neural oscillations modulation during working memory in premanifest and early Huntington’s disease
Objective: To test whether high-density electroencephalography (hdEEG) coupled to source localization allows for the identification of neuronal oscillations in specific frequency bands in patients with…Atypical gait in a patient with Huntington’s Disease (HD): Functional movement disorders in the spectrum of motor phenotypes in HD
Objective: We describe a case of Huntington’s disease (HD) associated chorea and concurrent functional movement disorder (FMD). Background: HD is a neurodegenerative disorder characterized by…Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme
Objective: To review studies for disease progression biomarkers published in HD and evaluate their methodological quality in a standardized manner. Background: Huntington disease (HD) is a fatal autosomal dominant neurodegenerative condition that starts to manifest clinically around the 4th decade of life. There are promising novel genetic-based therapies under development intended to modify the disease trajectory. Valid…Neural correlates of executed compared to imagined writing and drawing movements. An fMRI study
Objective: In this study we used functional magnetic resonance imaging (fMRI) to investigate whether motor imagery (MI) of handwriting and circle drawing activates a similar…Neutralizing Antibody Conversion With OnabotulinumtoxinA From Global Studies Across Multiple Indications With A Focus On Movement Disorders: A Meta-Analysis
Objective: A meta-analysis of clinical trial data across 10 indications for onabotulinumtoxinA was performed to assess incidence of neutralizing antibody (nAb) formation with a focus…Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up
Objective: Investigate the safety and efficacy of botulinum toxin type A in Parkinson´s disease and parkinsonism patients affected by sialorrhea Background: Sialorrhea is excessive salivation…Experiences of home-based dance participation in people with Parkinson’s
Objective: To investigate experiences of people with PD in using digital resources for home-based dance participation during the COVID-19 pandemic. Background: Dance is associated with…Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium
Objective: An update on the accomplishments of the Critical Path for Parkinson’s (CPP) Consortium. Background: The pharmaceutical pipeline for Parkinson’s disease (PD) is rapidly expanding. Data sharing will facilitate decision making during the development…Primary Palliative Care for Huntington Disease
Objective: To develop a pilot program integrating primary palliative care with interdisciplinary care for Huntington disease (HD). Goals: 1) train HD team members to facilitate…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 132
- Next Page »